Woo H, Jang Y, Kim S, et al. Pharmacological Targeting of the NLRP3 trLRR Domain with Isothiazolinones Overcomes CRID3-Resistant Inflammation. LTS. Published online January 30, 2026. doi:10.65215/LTSpreprints.2026.01.30.000113